Tesla pivot to robotaxis/robotics drives capex surge amid execution risks
Key Questions
What is driving Tesla's capital expenditure surge?
Tesla's pivot to robotaxis and robotics is driving a capex surge, including a $25 billion Terafactory in Austin with SpaceX, targeting AI5, 2nm chips, and 1TW capacity by mid-2028.
What are the details on Tesla's Cybercab production plans?
Cybercab production is ramping to over 500 Giga Texas in April at around $30k per unit, with 700k miles driven across 17 cities including Colorado, supported by RaceCar and Boston testing.
What is known about the upcoming Model 2?
The Model 2 is expected at $25-35k, featuring gigacasting, LFP batteries, aluminum-ion tech, and Robotaxi capabilities.
What updates are there for the Model Y Juniper?
Model Y Juniper includes HW4.5 refresh, efficiency improvements, 99.9% state of health retention, and 480km real-world range after 12k miles.
How did Tesla perform in Q1 deliveries?
Tesla delivered 358k vehicles in Q1, missing expectations with 50k excess inventory, but reached 9.24 million cumulative deliveries as the #1 BEV seller.
What changes have occurred with Model S and Model X production?
Fremont production of Model S and X has ended, with inventory prices increased by $15k; a $299 lease is available for Model 3.
What are the sales highlights in Asia for Tesla?
Model Y Long Range 6-seat launched in Japan; South Korea sales up 330% YoY to 11k in March; Malaysia expansion with SK.
What are the risks mentioned for Tesla's strategy?
Execution risks include regulatory delays, stock volatility, and competition from Rivian R2 (335mi EPA AWD at $45k H1 2026 with NACS rival).
$25B Terafab Austin w/SpaceX (AI5/2nm/1TW/mid-2028); Cybercab 500+ Giga TX April ramp (~$30k)/RaceCar/Boston/700k mi/17 cities/CO; Model 2 $25-35k gigacasting/LFP/Al-ion/Robotaxi; Model Y Juniper HW4.5 refresh/efficiency/99.9% SOH/480km real-world/12k mi; Rivian R2 335mi EPA AWD/$45k H1 2026 NACS rival; M3 $299 lease/cheaper Y/SX Fremont prod ends inventory +$15k/free FSD/SC; Y L Japan 6-seat/SK/Malaysia (SK March +330% YoY 11k); Q1 358k deliv miss (50k excess)/9.24M cumulative/#1 BEV; Optimus Gen3; 4680 Gen3 tabless; regulatory delays/stock risks.